Section 508 Website Accessibility

Skip to site navigation Skip to main content
Skip to main content
Chief of Staff

Chief of Staff

Office of Vice President and Chief of Staff
News and Media
Related Links

Office of Vice President and
Chief of Staff
Florida Gulf Coast University
10501 FGCU Blvd S.
Fort Myers, FL. 33965-6565

Phone: (239) 590-1006
Fax:     (239) 590-1066

Press Release


FGCU Hosts Seminar Jan. 27 to Discuss New Approaches to Treating Tuberculosis

FORT MYERS, FL - The Florida Gulf Coast University Biotechnology Seminar Series invites members of the public, healthcare community and media to "Tuberculosis: New Approaches to An Ancient Disease" 11 a.m., Thursday, Jan. 27 in the Whitaker Hall Sprint Room to learn about new developments in the prevention and treatment of tuberculosis.

"Tuberculosis is a serious reemerging public health problem," associate professor of biotechnology Scott F. Michael said.

"The rate of increase in TB cases in the U.S. currently is higher than it was in the 1920s and 30s, and many people possess a high level of antibiotic resistance to curing. TB today is becoming problematic."

The free seminar features speaker Clifton Barry III, head of the Tuberculosis Research Section at the National Institutes of Health in Rockville, Md.

Since 1998 when he was named head of the TRS, Barry has been highly involved in international activities to develop new chemotherapies for tuberculosis, serving as an advisor to both the World Health Organization and the Global Alliance for TB Drug Development.

Barry serves on the editorial boards of several professional journals and has authored more than 40 research publications on tuberculosis. He holds a Ph.D. from Cornell University in organic and bioorganic chemistry and conducted postdoctoral research at Johns Hopkins University.

The NIH's Tuberculosis Research Section () is dedicated to improving the chemotherapy of tuberculosis. Chemists, clinicians and microbiologists collaborate to identify new strategies to improve therapy by studying the natural history of the disease, advantages and shortcomings of current antibiotics, models for the evaluation of new antibiotics, and the underlying reasons for the development of drug resistance.

Further, scientists research areas such as the modification of new synthetic antitubercular compounds,the identification and optimization of products derived from natural sources with antitubercular activity, and the development of delivery methods and formulations.

Barry is the first speaker in the FGCU Biotechnology Seminar Series for spring 2005. Semimonthly through May, the series hosts a broad range of speakers from around the United States. The next presentation is Monday, Jan. 31 on "The reintroduction of the Bongo into Kenya, Africa" by Mark Davis, a veterinarian with the Peace River Center for Conservation of Tropical Ungulates in Arcadia.

For more information, contact Michael at (239) 590-7439 or .

[Back to the Press Release Archives]